The module <NameOfSystemFile> failed to load. Make sure the binary is sorted at the specified path or debug it to check for problems with the binary or dependent .DLL ...
About OSE Immunotherapeutics S.A. OSE Immunotherapeutics SA s is a biotechnology company, which engages in the research and development of pharmaceutical products. It focuses on developing and ...
Qbiss Notch, a new design edition developed by Pininfarina for Trimo's Qbiss façade system, has received the Red Dot Design Award. Based on Trimo's Qbiss façade technology, the project introduces ...
OSE Immunotherapeutics has shared phase 2 data on its neo-epitope vaccine candidate and Keytruda in ovarian cancer, linking maintenance use of the combination to improvements over best supportive care ...
In a year many deemed lackluster, the most interesting new tech of CES 2019 could not be found in a single one of the more than 4,000 exhibitor booths that populate the convention's 2.7 million square ...
Ose Okojie's 2024-25 college basketball season came to an end when the Howard Bison guard suffered a concussion during a game against the Maryland, Baltimore County (UMBC) Retrievers in November 2024.
After cutting down its pipeline just a few months ago, OSE Immunotherapeutics is at it again, this time reorganizing as Boehringer Ingelheim walks away from the biotech’s metabolic ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
One of the country's best known Irish traditional singers Seán Ó Sé has died. Mr Ó Sé would have been 90 on Friday. A renowned tenor singer, the retired schoolteacher was affectionately known as 'The ...
Some subscribers prefer to save their log-in information so they do not have to enter their User ID and Password each time they visit the site. To activate this function, check the 'Keep me signed in' ...
NANTES, France - March 26, 2025, 6:15 p.m. CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a biotech company dedicated to developing first-in-class therapies in immuno-oncology and ...
Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take a drubbing. But at OSE Immunotherapeutics, which aims to prevent cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results